Sanz Gómez, M., Manzano Lista, F. J., Vega Martín, E., González Moreno, D., Alcalá, M., Gil Ortega, M., . . . Fernández Alfonso, M. S. (2023). Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors.
Citación estilo ChicagoSanz Gómez, Marta, et al. Finerenone Protects against Progression of Kidney and Cardiovascular Damage in a Model of Type 1 Diabetes Through Modulation of Proinflammatory and Osteogenic Factors. 2023.
Cita MLASanz Gómez, Marta, et al. Finerenone Protects against Progression of Kidney and Cardiovascular Damage in a Model of Type 1 Diabetes Through Modulation of Proinflammatory and Osteogenic Factors. 2023.
Precaución: Estas citas no son 100% exactas.